Age class (years) | Population not included | Included but not contacted | Included and contacted | Total | Overall mortality | COVID-19 morbidity | COVID-19 hospitalisation | |||
N (%) | N (%) | N (%) | N | HR (95% CI) | OR (95% CI) | HR (95% CI) | OR (95% CI) | HR (95% CI) | OR (95% CI) | |
70–74 | 167 516 (33.8) | 16 049 (20.29) | 9370 (19.27) | 192 935 | 1# | 1# | 1# | 1# | 1# | 1# |
75–79 | 125 115 (25.24) | 17 347 (21.93) | 10 501 (21,6) | 152 963 | 1.67 (1.54 to 1.82) | 1.72 (1.57 to 1.89) | 1.28 (1.19 to 1.39) | 1.28 (1.19 to 1.39) | 1.27 (1.17 to 1.38) | 1.27 (1.17 to 1.38) |
80–84 | 108 993 (21.99) | 20 564 (25.99) | 12 778 (26.28) | 142 335 | 2.36 (2.18 to 2.56) | 2.56 (2.34 to 2.80) | 1.55 (1.43 to 1.67) | 1.54 (1.43 to 1.66) | 1.40 (1.29 to 1.51) | 1.39 (1.28 to 1.51) |
85–89 | 60 515 (12.21) | 15 646 (19.78) | 9863 (20.28) | 86 024 | 4.20 (3.87 to 4.55) | 5.21 (4.76 to 5.69) | 2.13 (1.97 to 2.31) | 2.12 (1.95 to 2.29) | 1.84 (1.69 to 2.01) | 1.82 (1.67 to 1.99) |
90+ | 33 530 (6.76) | 9504 (12.01) | 6113 (12.57) | 49 147 | 7.53 (6.95 to 8.15) | 10.98 (10.05 to 12.00) | 2.37 (2.16 to 2.60) | 2.32 (2.12 to 2.55) | 1.66 (1.49 to 1.85) | 1.61 (1.45 to 1.80) |
Gender | ||||||||||
Males | 199 309 (40.21) | 38 732 (48.96) | 23 808 (48.96) | 261 849 | 1# | 1# | 1# | 1# | 1# | 1# |
Females | 296 360 (59.79) | 40 378 (51.04) | 24 817 (51.04) | 361 555 | 0.40 (0.38 to 0.42) | 0.32 (0.31 to 0.34) | 0.53 (0.50 to 0.56) | 0.54 (0.51 to 0.56) | 0.43 (0.41 to 0.46) | 0.44 (0.41 to 0.46) |
Polytherapy | ||||||||||
No polytherapy/ no hypertherapy | 238 072 (48.03) | 9579 (12.11) | 4758 (9.79) | 252 409 | 1# | 1# | 1# | 1# | 1# | 1# |
Polytherapy | 189 447 (38.22) | 31 729 (40.11) | 19 038 (39.15) | 240 214 | 2.78 (2.61 to 2.96) | 2.76 (2.58 to 2.94) | 1.67 (1.57 to 1.78) | 1.65 (1.55 to 1.76) | 1.86 (1.73 to 1.99) | 1.83 (1.71 to 1.97) |
Hypertherapy | 68 150 (13.75) | 37 802 (47.78) | 24 829 (51.06) | 130 781 | 8.38 (7.84 to 8.96) | 10.27 (9.57 to 11.02) | 3.14 (2.92 to 3.38) | 3.04 (2.82 to 3.28) | 3.64 (3.35 to 3.95) | 3.51 (3.24 to 3.81) |
IBD and cirrhosis | ||||||||||
No | 492 858 (99.43) | 76 125 (96.23) | 46 724 (96.09) | 615 707 | 1# | 1# | 1# | 1# | 1# | 1# |
Yes | 2811 (0.57) | 2985 (3.77) | 1901 (3.91) | 7697 | 32.69 (10.54 to 101.46) | 66.57 (19.92 to 222.48) | 1.13 (0.91 to 1.40) | 1.10 (0.88 to 1.36) | 1.19 (0.94 to 1.51) | 1.16 (0.91 to 1.47) |
COPD | ||||||||||
No | 472 949 (95.42) | 63 154 (79.83) | 38 018 (78.19) | 574 121 | 1# | 1# | 1# | 1# | 1# | 1# |
Yes | 22 720 (4.58) | 15 956 (20.17) | 10 607 (21.81) | 49 283 | 34.64 (24.81 to 48.36) | 53.97 (38.26 to 76.12) | 1.67 (1.52 to 1.85) | 1.62 (1.47 to 1.78) | 1.56 (1.41 to 1.73) | 1.50 (1.36 to 1.67) |
Renal failure | ||||||||||
No | 490 711 (99) | 69 669 (88.07) | 42 293 (86.98) | 602 673 | 1# | 1# | 1# | 1# | 1# | 1# |
Yes | 4958 (1) | 9441 (11.93) | 6332 (13.02) | 20 731 | 9.31 (6.40 to 13.54) | 50.29 (37.54 to 67.37) | 1.73 (1.49 to 2.01) | 1.66 (1.43 to 1.93) | 1.72 (1.47 to 2.03) | 1.65 (1.40 to 1.94) |
Diabetes | ||||||||||
No | 426 120 (85.97) | 60 642 (76.66) | 36 973 (76.04) | 523 735 | 1# | 1# | 1# | 1# | 1# | 1# |
Yes | 69 549 (14.03) | 18 468 (23.34) | 11 652 (23.96) | 99 669 | 37.64 (28.24 to 50.16) | 93.23 (76.82 to 113.15) | 1.69 (1.56 to 1.82) | 1.64 (1.52 to 1.77) | 1.70 (1.57 to 1.84) | 1.65 (1.52 to 1.79) |
Cardiovascular | ||||||||||
No | 402 378 (81.18) | 18 878 (23.86) | 9958 (20.48) | 431 214 | 1# | 1# | 1# | 1# | 1# | 1# |
Yes | 93 291 (18.82) | 60 232 (76.14) | 38 667 (79.52) | 192 190 | 59.98 (49.76 to 72.31) | 374.8 (275.5 to 509.9) | 2.15 (2.02 to 2.29) | 2.07 (1.95 to 2.21) | 2.33 (2.17 to 2.49) | 2.24 (2.09 to 2.40) |
Neoplasms | ||||||||||
No | 405 885 (81.89) | 57 383 (72.54) | 34 658 (71.28) | 497 926 | 1# | 1# | 1# | 1# | 1# | 1# |
Yes | 89 784 (18.11) | 21 727 (27.46) | 13 967 (28.72) | 125 478 | 115.9 (87.4 to 153.6) | 39.88 (20.56 to 77.34) | 2.02 (1.86 to 2.19) | 1.95 (1.80 to 2.12) | 2.06 (1.89 to 2.25) | 1.99 (1.82 to 2.17) |
Autoimmune diseases | ||||||||||
No | 479 704 (96.78) | 74 124 (93.7) | 45 350 (93.26) | 599 178 | 1# | 1# | 1# | 1# | 1# | 1# |
Yes | 15 965 (3.22) | 4986 (6.3) | 3275 (6.74) | 24 226 | 32.16 (16.72 to 61.85) | 36.5 (19.0 to 70.2) | 1.89 (1.59 to 2.25) | 1.86 (1.57 to 2.22) | 1.90 (1.58 to 2.29) | 1.87 (1.55 to 2.26) |
Charlson index | ||||||||||
0 | 475 526 (95.94) | 60 557 (76.55) | 37 173 (76.45) | 573 256 | 1# | 1# | 1# | 1# | 1# | 1# |
1 | 5722 (1.15) | 6896 (8.72) | 4121 (8.48) | 16 739 | 7.88 (7.24 to 8.58) | 14.11 (12.50 to 15.94) | 3.21 (2.89 to 3.56) | 3.10 (2.79 to 3.45) | 2.70 (2.39 to 3.04) | 2.59 (2.29 to 2.92) |
2 | 1345 (0.27) | 3246 (4.1) | 2019 (4.15) | 6610 | 8.35 (7.46 to 9.35) | 20.12 (16.67 to 24.28) | 3.82 (3.27 to 4.47) | 3.61 (3.08 to 4.24) | 3.95 (3.35 to 4.65) | 3.72 (3.15 to 4.40) |
3 | 489 (0.1) | 1377 (1.74) | 849 (1.75) | 2715 | 7.98 (6.81 to 9.35) | 25.87 (19.14 to 34.96) | 3.76 (2.98 to 4.74) | 3.48 (2.74 to 4.42) | 3.25 (2.49 to 4.24) | 2.96 (2.26 to 3.88) |
4 | 111 (0.02) | 383 (0.48) | 232 (0.48) | 726 | 12.50 (9.33 to 16.75) | 60.20 (30.39 to 119.23) | 5.59 (3.82 to 8.17) | 5.29 (3.57 to 7.84) | 3.52 (2.14 to 5.79) | 3.22 (1.94 to 5.36) |
5+ | 12 476 (2.52) | 6651 (8.41) | 4231 (8.7) | 23 358 | 13.21 (12.22 to 14.30) | 48.32 (41.80 to 55.86) | 2.17 (1.91 to 2.46) | 2.03 (1.79 to 2.31) | 2.05 (1.79 to 2.36) | 1.92 (1.67 to 2.20) |
Influenza vaccination | ||||||||||
No | 255 513 (51.55) | 34 658 (43.81) | 16 989 (34.94) | 307 160 | 1# | 1# | 1# | 1# | 1# | 1# |
Yes | 240 156 (48.45) | 44 452 (56.19) | 31 636 (65.06) | 316 244 | 1.08 (1.03 to 1.13) | 1.09 (1.03 to 1.15) | 0.97 (0.92 to 1.03) | 0.97 (0.92 to 1.02) | 0.89 (0.84 to 0.95) | 0.89 (0.84 to 0.94) |
Pneumococcal vaccination | ||||||||||
No | 468 588 (94.54) | 70 699 (89.37) | 41 630 (85.61) | 580 917 | 1# | 1# | 1# | 1# | 1# | 1# |
Yes | 27 081 (5.46) | 8411 (10.63) | 6995 (14.39) | 42 487 | 0.79 (0.73 to 0.85) | 0.71 (0.64 to 0.78) | 0.98 (0.89 to 1.08) | 0.99 (0.90 to 1.09) | 0.95 (0.86 to 1.05) | 0.96 (0.87 to 1.06) |
Total | 495 669 (79.51) | 79 110 (12.69) | 48 625 (7.8%) | 623 404 | C-index 0.93 | C-index 0.70 | C-index 0.68 |
#Reference category